Clinical trial
Sifrol Onset of Action and Impact: a 12-weeks Observational Study in Patients With Primary RLS
NCT00721279 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sifrol Onset of Action and Impact: a 12-weeks Observational Study in Patients With Primary RLS
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2007
- Completion date
- Not reported
- Enrollment
- 549 (actual)
- Sites
- 127
Conditions
As the registry lists them; a condition with its own page is linked.